Eli Lilly hands Kumquat Biosciences $70M to kick off cancer drug R&D alliance July 29, 2021 Auto Bot BioPharma, biopharma nl, cancer, deals, Eli Lilly, Indianapolis, Pharma, San Diego 0 Eli Lilly is beginning a research alliance discovering and developing small molecules that stimulate immune responses against cancer. If drugs from the partnership reach the market, Kumquat could earn up to $2 billion in milestone payments.